BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 131 filers reported holding BIOSCRIP INC in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,165,000 | -64.0% | 3,043,453 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $8,796,000 | +96.6% | 3,043,453 | +73.5% | 0.00% | +100.0% |
Q2 2016 | $4,474,000 | +19.4% | 1,754,388 | +0.2% | 0.00% | 0.0% |
Q1 2016 | $3,748,000 | +20.6% | 1,751,568 | -1.4% | 0.00% | 0.0% |
Q4 2015 | $3,109,000 | -4.0% | 1,776,550 | +2.5% | 0.00% | 0.0% |
Q3 2015 | $3,240,000 | -49.6% | 1,732,507 | -2.1% | 0.00% | -50.0% |
Q2 2015 | $6,423,000 | -36.9% | 1,769,555 | -22.9% | 0.00% | 0.0% |
Q1 2015 | $10,172,000 | -32.2% | 2,296,113 | +7.0% | 0.00% | -50.0% |
Q4 2014 | $15,002,000 | +12.3% | 2,146,149 | +11.0% | 0.00% | 0.0% |
Q3 2014 | $13,361,000 | -18.0% | 1,933,615 | -1.0% | 0.00% | -20.0% |
Q2 2014 | $16,294,000 | +42.3% | 1,953,750 | +19.1% | 0.01% | +66.7% |
Q1 2014 | $11,452,000 | -5.4% | 1,640,681 | +0.2% | 0.00% | -25.0% |
Q4 2013 | $12,112,000 | -18.1% | 1,636,737 | -2.8% | 0.00% | -20.0% |
Q3 2013 | $14,781,000 | -39.3% | 1,683,455 | +14.2% | 0.01% | -44.4% |
Q2 2013 | $24,333,000 | – | 1,474,751 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
First Washington CORP | 454,200 | $3,788,000 | 2.12% |
GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |